Role of NO on pressure-natriuresis in Wistar-Kyoto and spontaneously hypertensive rats. We investigated the role of the endothelium-derived relaxing factor nitric oxide (NO) on pressure-natriuresis in spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY) using in vivo perfusion studies. Differences in the neural and hormonal background to the kidney were minimized by renal denervation and by holding plasma vasopressin, aldosterone, corticosterone, and norepinephnne levels constant by intravenous infusion. In WKY, elevation of renal perfusion pressure (RPP) from 115 to 157 mm Hg increased urinary sodium excretion 4.5 to 14.8 sEq/min/g kidney wt, and the slope of its linear regression was 0.21 Eq/min/g kidney wt/mm Hg. Infusion of an inhibitor of NO synthase, L-NMMA (1 mg/mm/kg), lowered this slope (P < 0.05) but L-arginine (3 mg/mm/kg) did not change it. By contrast, the impaired pressure-natriuresis response of SHR was ameliorated by L-arginine (slope: 0.08 to 0.16; P < 0.05), while L-NMMA did not blunt it further. GFR and renal plasma flow (RPF) were well autoregulated in both strains, but L-NMMA lowered RPF significantly (SHR: from 4.2 to 2.6 ml/min/g kidney wt; WKY: 4.5 to 2.5 ml/min/g kidney wt). Moreover, when infused simultaneously, all these individual effects of L-NMMA and L-arginine were nullified. These results suggest that NO plays an important role in the pressurenatriuresis mechanism.
dynamics, it is logical to assume that NO is an effective regulator of urine sodium excretion. However, there have been only a few investigations concerning the effect of NO on the pressure-natriuresis response [17] , and to our knowledge, no attempt has been made to characterize the participation of NO in the abnormalities of the pressure-natriuresis response in hypertensive rats.
The purpose of this study was, first, to investigate the role of NO in the mechanism of the pressure-natriuresis response. Second, the differential role of NO in both normotensive and hypertensive rats was examined. Studies were performed under conditions in which the neural and hormonal influences on the kidney were minimized.
Methods Animals Experiments were carried out on 48 adult (12-week old) male spontaneously hypertensive rats (Charles River Co., Kanagawa, Japan) and the same number of age and sex-matched Wistar Kyoto rats (Charles River) weighing around 280 g. All rats were fed on rat chow containing 0.38% sodium by weight and were allowed to drink water ad libitum; however, they were prohibited from feeding 12 hours before the surgical preparation.
Surgical preparation
The following preparation was performed according to the previous reports [2, 3, 8] . The right kidney was removed seven days before the experiment. Animals were anesthetized with an intraperitoneal injection of mactin (100 mg/kg), and tracheotomized to facilitate respiration. They were placed on a warm plate to maintain body temperature at 37°C. The left carotid and femoral arteries were cannulated (PE5O, Becton & Dickinson Company, New Jersey, USA) to measure arterial blood pressure above and below the left renal artery. Blood pressure was monitored with a transducer (TP400T, Nihon Koden, Tokyo, Japan) and an amplifier (AP6O1G, Nihon Koden), The left external jugular vein was cannulated (PE5O) for the administration of saline containing 1% bovine serum albumin, 1% inulin, 0.1% para-aminohippurate (PAR), norepinephrine (1.0 ng/pi), Company) was placed in the left ureter for the collection of urine. Two adjustable clamps were placed on the aorta, one above and one below the left renal artery. Silk ligatures were placed loosely around the superior mesenteric and celiac arter-
ies. An equilibrium period of 60 minutes was then allowed before each of the following experiments.
Characterization of the pressure-natriuresis relationship of SHR and WKY with 
or L-arginine treatment Twenty-four SHR and the same number of WKY rats were used and they were divided into four groups (N = 6/group), respectively.
L-NMMA groups (mean body weight: WKY285 5 g, SHR 281 5 g). After the equilibration period, a competitive inhibitor of NO synthase, L-NMMA (1 mg/mm/kg, Sigma Chemical Co., St. Louis, Missouri, USA) was added to the saline vehicle and infused throughout the experiment. After a 15-minute lead-in, renal perfusion pressure (RPP) was lowered to approximately 130 mm Hg in both SHR and WKY by tightening the clamp above the renal artery. We initially intended to lower RPP to approximately 110 mm Hg in WKY, however, there was a significant rise in blood pressure within five minutes of L-NMMA administration, and therefore we could not stabilize the blood pressure level of WKY at 110 mm Hg. After a 15-minute equilibration period, the first clearance study was performed. This clearance study, as well as the second and the third clearance studies, consisted of two 15-minute clearance periods with 400 d of arterial blood sampling at the midpoint of each period, and measurement of blood pressure. Immediately after the each blood sampling, an equal volume of arterial blood was transfused from similarly treated littermate donor. Values obtained from the two clearance periods were averaged and used for analysis. RPP was then adjusted to approximately 160 mm Hg in both strains by releasing the aortic clamp above the renal artery, and if necessary, partially occluding the one below the renal artery. After a 15-minute equilibration period, the second clearance study was performed in the same manner as the first clearance study. Then RPP was increased to approximately 190 mm Hg in both strains by tightening the clamp below the renal artery and occluding the mesenteric and celiac arteries. After another 15-minute equilibration period, the third clearance study was also carried out in the identical manner. Therefore, in the L-NMMA administered WKY rats, their RPP levels were adjusted around 130, 160, and 190 mm Hg, whereas in the following groups, they were adjusted around 110, 130, and 160 mm Hg.
L-arginine groups (mean body weight: WKY277 4g, SHR 280 5 g). A substrate of NO synthase, L-arginine (3 mg/minI kg, Sigma Chemical Co.) was added to the saline vehicle instead of L-NMMA. This ratio of L-argmine to L-NMMA was decided from previous in vivo and in vitro studies [18, 19] . The other experimental protocol was the same as the L-NMMA groups; RPP was adjusted around 130, 160, and 190 mm Hg in SHR and 110, 130, and 160 mm Hg in WKY, respectively.
L-NMMA + L-argifline groups (mean body weight: WKY275 5 g, SHR 270 5 g). In this subset of groups, both L-NMMA (1 mg/mm/kg) and L-arginine (3 mg/mm/kg) were added to the saline vehicle and infused simultaneously. The other experimental protocol and RPP levels were the same as the L-argirnne groups.
Control groups (mean body weight: WKY28I 5 g, SHR 276 5 g). In the control SHR and WKY rats, the saline vehicle described in Surgical preparation was infused at the same rate throughout the study. After the surgery and the 60-minute equilibrium period, another 15-minute equilibration period was allowed instead of the lead-in period in the previous groups.
Clearance studies were then performed in the same fashion as in the L-arginine groups.
Urinary NO2 /N0j excretion in SHR and WKY rats Experiments were designed to study the response of NO release in normotensive and hypertensive rats. Urinary excretion of NO metabolites (NO2 and/or NO3-) was measured as an index of NO release. Twenty-four SHR and 24 WKY rats were divided into four groups (N = 6/group), respectively. They were instrumented as described in Surgical preparation, except that femoral artery was not cannulated and the aortic clamps were not placed.
After the surgical preparation, rats were allowed to equilibrate for 60 minutes. In the first groups of SHR (mean body weight: 276 4 g) and WKY (278 5 g), L-NMMA (1 mg/mm/kg) was added to the infusate and continued throughout the rest of the experiment. In the second groups (SHR 281 S g, WKY 279 4 g), L-arginine (3 mg/mm/kg) was added to the infusate instead of L-NMMA. In the third groups (SHR 271 5 g, WKY 274 4 g), both L-NMMA (1 mg/mm/kg) and L-arginine (3 mg/mm/kg) were added to the infusate at the same time. Rats were allowed to equilibrate for 20 minutes, then urine was collected for 30 minutes and systemic blood pressure was measured. Time control SHR (276 5 g) and WKY (280 5 g) rats were prepared in a similar fashion and given the saline vehicle throughout the study. They were allowed to equilibrate for 80 minutes before the 30-minute clearance period.
Analysis and statistics Urine volume was measured gravimetrically, and urine flow rate was factored per gram kidney weight. Sodium concentrations were measured with a flame photometer. Glomerular filtration rate (GFR) and renal plasma flow (RPF) were calculated as the ratio of the urine/plasma concentration of inulin and PAH multiplied by the urine flow rate, respectively. Filtration fraction (FF) was calculated as the ratio of GFR to RPF. NO2/N03 concentration was measured by automated system TCI-NOX 1000 (Tokyo Kasei Kogyo Co., Tokyo, Japan) based on colorimetric methods [20, 21] . The intra-assay coefficient of variation was 0.35%.
Values are given as means SEM. Statistical significance of differences in individual values were checked using analysis of variance or unpaired t-tests, as appropriate. Linear regression analysis was used to calculate the slopes of the lines relating sodium excretion and RPP. Differences in the slopes of these lines were compared using an unpaired t-test. Significance of difference in urinary N02/N03 excretion was determined using two-way analysis of variance. P < 0.05 was acknowledged as statistically significant.
Results
The effects of renal perfusion pressure and L-NMMA or L-arginine infusion on renal function were summarized in Table  1 . In both control SHR and control WKY, glomerular filtration rate was preserved almost constant in the range of renal perfusion pressure studied (l30-l90 mm Hg in SHR and 1 10-160 mm Hg in WKY). This autoregulation of glomerular filtration rate was not affected by the administration of either L-NMMA or L-arginine. Moreover, the absolute value of the glomerular filtration rate did not differ significantly between the two strains. Renal plasma flow was also well autoregulated in both SHR and WKY control rats. However, with the administration of L-NMMA, the renal plasma flow was significantly reduced in both strains. When compared with the respective control rats at the same blood pressure level (160 mm Hg in SHR and 130 mm Hg in WKY), the absolute values were as low as 62% in SHR and 56% in WKY. As a result, L-NMMA infusion caused a significant rise in filtration fraction in both strains ( Table 1) . Administration of L-arginine alone did not cause any significant effect on renal plasma flow and filtration fraction, however, when infused simultaneously, L-arginine effectively reversed tnese hemodymanic changes caused by L-NMMA infusion. Figure 1 illustrates the effect of L-NMMA administration on the pressure-natriuresis relationship of both strains. As reported previously [22, 23] , the pressure-natriuresis curve of Eq/min/g kidney wt/mm Hg, P < 0.05). On the contrary, when L-arginine alone was infused, its natriuretic effect was statisti-* * cally significant only in SHR (Fig. 2) . Compared with control 160 SHR, the pressure-natriuresis curve of L-argirnne infused SHR was shifted to the left and its slope was elevated significantly (0.16 Eq/niinIg kidney wtlmm Hg vs. 0.08 Eq/min/g kidney g 140
wt/mm Hg, P < 0.)5). Therefore, the impaired pressurenatriuresis of SHR was improved by L-arginine, but was not blunted further by L-NMMA. In contrast, the pressure-natri-120 uresis response of WKY was significantly deteriorated by L-NMMA, however, L-arginine did not enhance it further. Figure 3 illustrates the result of the simultaneous infusion of L-NMMA and L-arginine. The concomitant administration nearly abolished either effect of L-NMMA or L-arginine, and the pressure-natriuresis curves of these co-infused animals did not differ significantly from those of respective controls. Figure 4 shows the effects of L-NMMA and/or L-arginine administration on systemic blood pressure in both strains. Addition of L-NMMA to the infusate evoked marked blood pressure elevation in both SHR (155 3 mm Hg vs. 170 5 mm Hg, P < 0.05) and WKY (138 1 mm Hg vs. 157 6 mm Hg, P < 0.01). L-argirnne lowered systemic blood pressure significantly in WKY (131 2 mm Hg, P < 0.05), but the difference did not reach statistical significance in SHR (149 3 mm Hg, P = 0.07). When infused simultaneously, L-NMMA and L-arginine had no effect on systemic blood pressure in either SHR N02/N03 between SHR and WKY (10.4 1.0 nM/min/g kidney wt vs. 7.7 0.6 nM/minlg kidney wt, P < 0.05).
However, when two-way analysis of variance was applied to the overall data, the difference was not significant (P = 0.10). Two-way analysis of variance also indicated that there were differences in urinary N02/N03 excretion among the L-NMMA, L-arginine, L-NMMA + L-arginine, and control groups (P < 0.001), and there was no interaction between treatment and strain of rat (P = 0.66). L-NMMA administration caused significant decrease in NO2/NO3 excretion in both SHR (5.5 1.0 nM/min/g kidney wt, P < 0.01) and WKY (4.4 0.8 nM/min/g kidney wt, P < 0.01). In contrast, addition of and glomerular filtration rate are consistent with those of previous studies [15, 19, [26] [27] [28] , recent studies have shown that administration of a smaller amount of L-NMMA did not induce any significant changes in sodium excretion in dogs [29, 30] . These differences may be due to differences in animal species, doses of L-NMMA [31] , or experimental designs. The presence of intact renal nerves and hormonal responses may have antagonized the sodium-retentive effect of L-NMMA in those studies [8] . However, the possibility that some of the hormones infused in this study may have the potential to alter NO synthesis or its action directly must also be considered [32] . L-arginine infusion into WKY failed to enhance their pressure-natriuresis curve, and L-NMMA infusion did not blunt that of SHR. The possibility that the doses used were too small must Control NMMA L-arginine NMMA be considered first. However, this possibility seems low, be-+ cause the urinary excretion of NO metabolites was significantly decreased or increased by infusion of the same dose of i-NMMA or L-arginine, respectively. In addition, the doses used in our study were equivalent to those employed in previous in vivo studies [26, 33] . Therefore, our observation that administration of L-arginine to WKY caused a significant increase in the urinary NO2/N03 excretion without further NO is synthesized from L-arginine, and its metabolites are excreted into urine as N02/NO3 [34, 35] . At present, it is impossible to measure NO in the blood, because its half life is in the order of only seconds and many substances including hemoglobin interfere with its measurement. In contrast, NO2-! N03 is stable in the blood or urine, and its measurement is feasible [21] . Although the question whether urinary NO2-! NO3 -reflects mainly systemic or local generation of NO Discussion remains unanswered, measurement of urinary N02/NO3
In this study, we examined the role of NO in the regulation of may, at least in part, estimate NO release. the pressure-natriuresis response in both normotensive and
We have demonstrated in this study that the deficiency in NO hypertensive rats. L-NMMA infusion markedly blunted the system may be one of the responsible factors for the impaired pressure-natriuresis curve of WKY, while L-arginine adminis-pressure-natriuresis in SHR. When we compare the urinary tration improved that of SHR. These effects on the pressure-excretion of NO2/NO3 between the control SHR and WKY natriuresis response are considered to be NO mediated, be- (Fig. 5) , the results are seemingly puzzling, because SHR cause they were effectively reversed by the concomitant excretes similar amount of NO metabolites as WKY does.
infusion of L-NMMA and L-arginine. In all cases, there were no However, in our recent study, we have shown that urinary changes in the glomerular filtration rate. This finding indicates NO2/N03 excretion was increased by mechanical blood that it was not the filtered sodium load on the glomeruli but its pressure elevation and this increase was abolished by L-NMMA handling thereafter that was altered, suggesting that NO mod- [20] . Therefore, the marked difference in mean blood pressure ulates tubular sodium reabsorption. It has been suggested that between the two strains (Fig. 4 ) must be considered in the suppression of tubular sodium reabsorption due to interstitial assessment of the basal NO2/NO3 excretion. hydrostatic pressure elevation is essential to the mechanism of It is interesting to note that when two-way analysis of pressure-natriuresis response, and that papillary hemodynam-variance was applied to the overall data, the difference of ics plays a critical role in the regulation of the interstitial urinary NO2/NO3 excretion between SHR and WKY was not hydrostatic pressure [24, 25] . It is therefore logical to propose significant. This indicates that in adult WKY and SHR, endothat NO, with its prominent vasodilating action, participates in thelial NO synthesis respond similarly to NO inhibition or the pressure-natriuresis response through regulation of intra-stimulation. In spite of this fact, their pressure-natriuresis renal blood flow distribution. Although our results concerning curves changed differently in these conditions. Therefore, in L-arginine increased urinary excretion of N02/NO3 more than twofold in both SHR (21.5 3.5 nM/min/g kidney wt, P < 0.01) and WKY (18.8 2.4 nM/min/g kidney weight, P < 0.001). From these data, it was demonstrated that the urinary excretion of NO metabolites was significantly decreased or increased by the infusion of the same dose of L-NMMA or L-arginine which were employed in the pressure-natriuresis studies. It was also confirmed that addition of three times larger dose of L-arginine (3 mg/mm/kg) to L-NMMA (1 mg/mm/kg) almost reversed the excretion of urinary NO metabolites to the control levels (SHR:
12.1 1.3 nM/min/g kidney wt, P = 0,18; WKY: 10.2 1.5 nM/min/g kidney wt, P = 0.07).
SHR, it is likely that their ability of NO synthesis was preserved while their renal response to NO was impaired.
Previous studies from our laboratory have demonstrated the importance of the intrarenal renin-angiotensin system in the pressure-natriuresis response in SHR [2] . Since a growing amount of evidence suggests an intimate relations between the renin-angiotensin system and NO , it is possible that the former modulates the pressure-natriuresis response through the latter. Further, the vascular endothelium is also able to generate vasoactive substances like endothelin and its interaction with NO has been recognized [391. Combining these findings, it is likely that in the kidney, complex interactions among NO, endothelin, and the renin-angiotensin system exist, affecting the pressure-natriuresis response. However, it has been reported that in dogs, inhibition of angiotensin-converting enzyme did not influence the renal responses to NO blockade [28] . Therefore, further studies are absolutely necessary before a conclusion can be drawn.
In summary, we have demonstrated the importance of NO in the maintenance of the normal pressure-natriuresis response.
Dysfunction of this system is partly responsible for the impaired pressure-natriuresis in SHR. These data suggest that disturbance in endothelial control of the renal function could play some role in the pathogenesis of hypertension.
